Scopus BioPharma (SCPS) News Today → Better than Bitcoin? The Biotech Stock with 46,751% Potential (From Behind the Markets) (Ad) Free SCPS Stock Alerts $0.0011 0.00 (0.00%) (As of 04/26/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartCompetitorsFinancialsInsider TradesSEC FilingsSocial MediaStock AnalysisChartCompetitorsFinancialsInsider TradesSEC FilingsSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineArgent Biopharma Stock (OTC:MGCLF), Quotes and News Summarybenzinga.com - April 17 at 10:54 AMScopus Biopharma Inc (SCPS)uk.investing.com - February 14 at 10:10 AMArriVent BioPharma Inc AVBPmorningstar.com - February 7 at 12:27 AMScopus BioPharma Inc. (SCPS)finance.yahoo.com - January 31 at 6:43 PM7+ Companies That Had Their IPO in 2020: Best and Worst Performersmsn.com - January 8 at 2:19 PMScopus BioPharma’s Subsidiary — Duet BioTherapeutics — Presents Compelling New Data for a Novel Treatment for Malignant Glioma at 38th Annual Meeting of the Society for Immunotherapy of Cancerfinance.yahoo.com - November 7 at 9:38 AMScopus BioPharma’s Subsidiary — Duet BioTherapeutics — to Present at the 38th Annual Meeting of the Society for Immunotherapy of Cancerfinance.yahoo.com - November 2 at 9:23 AMKinnate Biopharma Inc Ordinary Sharesmorningstar.com - July 15 at 7:42 PMScopus BioPharma Stock (OTC:SCPS), Insider Trading Activitybenzinga.com - May 16 at 8:53 PMESG Industry Landscape Report: Biopharmamorningstar.com - April 19 at 7:56 PMYS BIOPHARMA TO RING THE OPENING BELL AND DEBUT ON NASDAQbenzinga.com - March 18 at 5:54 PMShort Volatility Alert: Scopus Biopharma Ibenzinga.com - December 16 at 5:42 PMWhy Planet Labs Shares Are Trading Higher; Here Are 28 Stocks Moving Premarketmsn.com - December 15 at 9:03 AMScopus BioPharma’s Subsidiary — Duet BioTherapeutics — Announces Key Scientific Data to be Presented at the 37th Annual Meeting and Exposition of the Society for Immunotherapy of Cancerfinance.yahoo.com - November 10 at 12:54 PMScopus Biopharma Completes Recapitalization Designed To Enhance Shareholder Valuefinance.yahoo.com - October 18 at 6:07 PMScopus BioPharma Announces Biotechnology Industry Leader Rejoins Board of Directorsfinance.yahoo.com - May 5 at 9:32 AMScopus BioPharma’s Subsidiary — Duet BioTherapeutics — to Present at the 3rd Annual STING & TLR-Targeting Therapies Summitfinance.yahoo.com - March 22 at 9:00 PMScopus BioPharma Provides Update Following Annual Meeting of Stockholdersfinance.yahoo.com - January 10 at 2:12 PMDR. MORRIS C. LASTER WINS PROXY CONTEST AS STOCKHOLDERS ELECT HIS NOMINEES TO SCOPUS BIOPHARMA INC. BOARD OF DIRECTORSfinance.yahoo.com - January 6 at 8:23 AMScopus Biopharma Inc Shares Approach 52-Week Low - Market Movernasdaq.com - December 28 at 7:37 AMScopus BioPharma Issues Open Letter to Stockholders Detailing Morris Laster’s Campaign Against the Companyfinance.yahoo.com - December 17 at 10:28 AMScopus BioPharma Sends Letter Urging Stockholders to Vote “FOR ALL” of the Company’s Director Nominees on the WHITE Proxy Cardfinance.yahoo.com - December 7 at 11:47 AMDr. Morris C. Laster Issues An Open Letter To Scopus BioPharma Inc. Stockholders In Connection With Upcoming Annual Meetingfinance.yahoo.com - December 6 at 7:59 AMScopus BioPharma Announces $9.75 Million Private Placement Priced At-The-Marketfinance.yahoo.com - November 22 at 12:54 PMScopus BioPharma Announces Adjournment of Annual Meeting of Stockholdersfinance.yahoo.com - October 8 at 7:26 PMScopus BioPharma to Present at the LD Micro Main Eventfinance.yahoo.com - October 5 at 12:45 PMScopus BioPharma Retaining Counsel to Investigate Unusual Market Activityfinance.yahoo.com - October 1 at 8:32 PMScopus BioPharma to Present at MicroCap Rodeo’s Fall Harvest Best Ideas Conferencefinance.yahoo.com - October 1 at 10:17 AMScopus BioPharma's Subsidiary — Duet Therapeutics — Announces Release of Preclinical Data Being Presented at 17th Annual Meeting of the Oligonucleotide Therapeutics Societyfinance.yahoo.com - September 29 at 6:11 PMScopus BioPharma’s Subsidiary — Duet Therapeutics — Set to Release Scientific Data During the ...apnews.com - September 28 at 9:33 AMScopus BioPharma to Adjourn 2021 Annual Meeting of Stockholdersfinance.yahoo.com - September 28 at 9:33 AMScopus BioPharma’s Subsidiary Duet Therapeutics Set to Release Scientific Data During the 17th Annual Meeting of the Oligonucleotide Therapeutics Societyfinance.yahoo.com - September 28 at 9:33 AMScopus BioPharma to Present at the Benzinga Healthcare Small Cap Conferencefinance.yahoo.com - September 23 at 9:16 AMChina National Intellectual Property Administration Grants New Patent Covering DUET-02, One of Three Key CpG-STAT3 Inhibitors Comprising the Duet Platformfinance.yahoo.com - September 21 at 2:26 PMDr. Morris C. Laster Files Preliminary Proxy Statement Nominating Two Highly-Qualified Individuals For Election To Board At Scopus BioPharma Inc.'s 2021 Annual Meetingfinance.yahoo.com - September 20 at 10:08 AMScopus BioPharma’s Subsidiary — Duet Therapeutics — Announces Appointments of John Rossi, Ph.D. and Nagy Habib, Ch.M., F.R.C.S. to the Scientific Advisory Boardfinance.yahoo.com - September 14 at 5:41 PMScopus BioPharma to Present at H.C. Wainwright 23rd Annual Global Investment Conferencefinance.yahoo.com - September 9 at 3:54 PMScopus BioPharma's Subsidiary -- Duet Therapeutics -- Announces Appointment of Marcin Kortylewski, Ph.D. as Senior Scientific Advisormarketwatch.com - September 9 at 2:08 AMScopus BioPharma’s Subsidiary — Duet Therapeutics — Announces Appointment of Marcin ...apnews.com - September 8 at 4:35 AMScopus BioPharma's Subsidiary - Duet Therapeutics - Announces Appointment of Marcin Kortylewski, Ph.D. as Senior Scientific Advisorstockhouse.com - September 7 at 6:34 PMScopus BioPharma’s Subsidiary — Duet Therapeutics — Announces Appointment of Marcin Kortylewski, Ph.D. as Senior Scientific Advisorfinance.yahoo.com - September 7 at 1:33 PMScopus BioPharma's Subsidiary - Duet Therapeutics - to Present at the 14th Annual RNA Consortium Meetingstockhouse.com - September 4 at 11:22 PMScopus BioPharma's Subsidiary — Duet Therapeutics — to Present at the 14th Annual RNA Consortium Meetingbenzinga.com - September 3 at 4:12 PMScopus BioPharma’s Subsidiary — Duet Therapeutics — to Present at the 14th Annual RNA ...apnews.com - September 3 at 4:12 PMScopus BioPharma’s Subsidiary — Duet Therapeutics — to Present at the 14th Annual RNA Consortium Meetingfinance.yahoo.com - September 3 at 4:12 PMScopus BioPharma Launches Duet Therapeuticsfinance.yahoo.com - September 2 at 6:16 PMmarketbeat.com - September 2 at 9:34 AMmarketbeat.com - August 4 at 3:19 PMScopus BioPharma Inc.barrons.com - July 25 at 7:46 PM Get Scopus BioPharma News Delivered to You Automatically Sign up to receive the latest news and ratings for SCPS and its competitors with MarketBeat's FREE daily newsletter. Email Address Protect Yourself While There’s Still Time … (Ad)The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom. 4 simple steps to protect your privacy and money before it’s too late. SCPS Media Mentions By Week SCPS Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SCPS News Sentiment▼0.000.32▲Average Medical News Sentiment SCPS News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SCPS Articles This Week▼00▲SCPS Articles Average Week Get Scopus BioPharma News Delivered to You Automatically Sign up to receive the latest news and ratings for SCPS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Statera Biopharma News Today Novan News Today Bruush Oral Care News Today Humanigen News Today Peak Bio News Today Context Therapeutics News Today Grifols News Today LAVA Therapeutics News Today Mainz Biomed News Today NLS Pharmaceutics News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:SCPS) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersThese AI trades triggered this morning (545% return)Prosper Trading AcademyConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersFed launches fourth dollar overhaulStansberry ResearchBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressA.I. is a Tidal Wave - Here’s What to BuyChaikin Analytics Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Scopus BioPharma Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
